Jenna H. Rannikko

All papers authored by Jenna H. Rannikko

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2024 Jenna H. Rannikko

, Petri Bono, Johanna Hynninen, Maija Hollmén

Figure S5 from Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments

Upload

Jenna H. Rannikko

, Petri Bono, Johanna Hynninen, Maija Hollmén

Figure S3 from Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments

Upload

Jenna H. Rannikko

, Petri Bono, Johanna Hynninen, Maija Hollmén

Data from Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments

Upload

Jenna H. Rannikko

, Petri Bono, Johanna Hynninen, Maija Hollmén

Figure S6 from Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments

Upload

Jenna H. Rannikko

, Petri Bono, Johanna Hynninen, Maija Hollmén

Table S2 from Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments

Upload

Jenna H. Rannikko

, Petri Bono, Johanna Hynninen, Maija Hollmén

Figure S1 from Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments

Upload

Jenna H. Rannikko

, Petri Bono, Johanna Hynninen, Maija Hollmén

Figure S7 from Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments

Upload

Jenna H. Rannikko

, Petri Bono, Johanna Hynninen, Maija Hollmén

Figure S2 from Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments

Upload

Jenna H. Rannikko

, Petri Bono, Johanna Hynninen, Maija Hollmén

Figure S4 from Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments

Upload

Jenna H. Rannikko

, Petri Bono, Johanna Hynninen, Maija Hollmén

Table S1 from Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments

Upload

This paper was not found in any repository, but could be made available legally by the author.

2023 Jenna H. Rannikko

, Petri Bono

, Johanna Hynninen

, Maija Hollmén

Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments

Upload

Maija Hollmén, Mikael Maksimow, Jenna H. Rannikko

, Matti K. Karvonen, Marita Vainio, Sirpa Jalkanen, Markku Jalkanen, Jami Mandelin

Data from Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers

Upload

Maija Hollmén, Mikael Maksimow, Jenna H. Rannikko

, Matti K. Karvonen, Marita Vainio, Sirpa Jalkanen, Markku Jalkanen, Jami Mandelin

Supplementary Table from Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers

Upload

Maija Hollmén, Mikael Maksimow, Jenna H. Rannikko

, Matti K. Karvonen, Marita Vainio, Sirpa Jalkanen, Markku Jalkanen, Jami Mandelin

Supplementary Figure from Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers

Upload

Maija Hollmén, Mikael Maksimow, Jenna H. Rannikko

, Matti K. Karvonen, Marita Vainio, Sirpa Jalkanen, Markku Jalkanen, Jami Mandelin

Supplementary Data from Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers

Upload

This paper is made freely available by the publisher.

2022 Maija Hollmén

, Mikael Maksimow

, Jenna H. Rannikko

, Matti K. Karvonen

, Marita Vainio

, Sirpa Jalkanen

, Markku Jalkanen

, Jami Mandelin

Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers

Download from aacrjournals.org

2021 Reetta Virtakoivu

, Jenna H. Rannikko

, Miro Viitala, Felix Vaura

, Akira Takeda

, Tapio Lönnberg, Jussi Koivunen, Panu Jaakkola

, Annika Pasanen, Shishir Shetty

, Maja J. A. de Jonge, Debbie Robbrecht

, Yuk Ting Ma, Tanja Skyttä, Anna Minchom

and 5 other authors

Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial

Upload

2019 Miro Viitala, Reetta Virtakoivu, Sina Tadayon, Jenna Rannikko

, Sirpa Jalkanen, Maija Hollmén

Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8+ T-cell Response against Immunosuppressive Tumors

Download from aacrjournals.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Jenna H. Rannikko